| Ravi Vaela, MD | |
|
490 S Maple St, Suite 216, Waconia, MN 55387-1760 | |
| (952) 442-2191 | |
| (952) 442-8081 |
| Full Name | Ravi Vaela |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 31 Years |
| Location | 490 S Maple St, Waconia, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184691826 | NPI | - | NPPES |
| 492478100 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 01051926 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ridgeview Medical Center | Waconia, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ridgeview Medical Center | 9234041997 | 193 |
News Archive
CQ Politics reports that Rep. Mary Jo Kilroy, D-Ohio, is one of several women lawmakers who is using her own history with multiple sclerosis to lobby for changes in the health care system: "As the health care debate rages on, [Kilroy] has decided to use her personal story to help fellow lawmakers understand how important it is to make health care available for all Americans. In a 'Dear Colleague' letter she sent last week, Kilroy told them about her own diagnosis."
Vice President Joe Biden warned that the plan drafted by House Budget Committee Chairman Paul Ryan, R-Wis., would hurt Medicare and Medicaid, while a Republican spokesman criticized Biden for his support of a blueprint that leaves the health law in place.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.
Now the United Nations health agency is investigating reports that bird flu, which experts say could mutate into a potentially deadly human pandemic under certain conditions, has now jumped the species barrier to infect cats.
Bio-Path Holdings, Inc., a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today that the U.S. Food and Drug Administration has allowed an IND (Investigational New Drug) for the Company's lead cancer drug candidate liposomal Grb-2 to proceed into clinical trials.
› Verified 7 days ago
| Entity Name | Ridgeview Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528364429 PECOS PAC ID: 9234041997 Enrollment ID: O20031111000183 |
News Archive
CQ Politics reports that Rep. Mary Jo Kilroy, D-Ohio, is one of several women lawmakers who is using her own history with multiple sclerosis to lobby for changes in the health care system: "As the health care debate rages on, [Kilroy] has decided to use her personal story to help fellow lawmakers understand how important it is to make health care available for all Americans. In a 'Dear Colleague' letter she sent last week, Kilroy told them about her own diagnosis."
Vice President Joe Biden warned that the plan drafted by House Budget Committee Chairman Paul Ryan, R-Wis., would hurt Medicare and Medicaid, while a Republican spokesman criticized Biden for his support of a blueprint that leaves the health law in place.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.
Now the United Nations health agency is investigating reports that bird flu, which experts say could mutate into a potentially deadly human pandemic under certain conditions, has now jumped the species barrier to infect cats.
Bio-Path Holdings, Inc., a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today that the U.S. Food and Drug Administration has allowed an IND (Investigational New Drug) for the Company's lead cancer drug candidate liposomal Grb-2 to proceed into clinical trials.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ravi Vaela, MD 490 S Maple St, Suite 216, Waconia, MN 55387-1760 Ph: (952) 442-2191 | Ravi Vaela, MD 490 S Maple St, Suite 216, Waconia, MN 55387-1760 Ph: (952) 442-2191 |
News Archive
CQ Politics reports that Rep. Mary Jo Kilroy, D-Ohio, is one of several women lawmakers who is using her own history with multiple sclerosis to lobby for changes in the health care system: "As the health care debate rages on, [Kilroy] has decided to use her personal story to help fellow lawmakers understand how important it is to make health care available for all Americans. In a 'Dear Colleague' letter she sent last week, Kilroy told them about her own diagnosis."
Vice President Joe Biden warned that the plan drafted by House Budget Committee Chairman Paul Ryan, R-Wis., would hurt Medicare and Medicaid, while a Republican spokesman criticized Biden for his support of a blueprint that leaves the health law in place.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.
Now the United Nations health agency is investigating reports that bird flu, which experts say could mutate into a potentially deadly human pandemic under certain conditions, has now jumped the species barrier to infect cats.
Bio-Path Holdings, Inc., a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today that the U.S. Food and Drug Administration has allowed an IND (Investigational New Drug) for the Company's lead cancer drug candidate liposomal Grb-2 to proceed into clinical trials.
› Verified 7 days ago
Paul E. Brown, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 424 W State Highway 5, Waconia, MN 55387 Phone: 952-442-4461 Fax: 952-442-4419 | |
Dr. Barrett Paul Larson Ii, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 560 S Maple St Ste 400, Waconia, MN 55387 Phone: 952-442-8011 Fax: 952-442-7852 | |
Dr. Tara Lynn Mcmichael, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 424 W State Highway 5, Waconia, MN 55387 Phone: 952-442-4461 | |
Henry M Dvorak, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-2191 Fax: 952-442-6535 | |
Dr. John Michael Peitersen, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 424 W State Highway 5, Waconia, MN 55387 Phone: 952-442-4461 | |
Sabina Khan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 560 S Maple St, Suite Number 220, Waconia, MN 55387 Phone: 952-442-8011 |